| |
| |
|
| Insider
Information: |
Laliberte Kevin |
| Relationship: |
Sr. VP, Product Develo... |
| City: |
Durham |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dova Pharmaceuticals, Inc. |
DOVA |
Sr. VP, Product Develo... |
2019-11-12 |
0 |
2017-07-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
7 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DOVA |
Dova Pharmaceuticals, Inc... |
Sr. VP, Product Development |
• – – |
2019-11-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,761) |
0 |
0 |
- |
|
| DOVA |
Dova Pharmaceuticals, Inc... |
Sr. VP, Product Development |
• – – |
2019-09-30 |
4 |
AS |
$28.00 |
$103,488 |
D/D |
(3,696) |
4,761 |
0 |
- |
|
| DOVA |
Dova Pharmaceuticals, Inc... |
Sr. VP, Product Development |
• – – |
2019-09-25 |
4 |
AS |
$20.00 |
$62,000 |
D/D |
(3,100) |
8,457 |
0 |
- |
|
| DOVA |
Dova Pharmaceuticals, Inc... |
Sr. VP, Product Development |
• – – |
2019-07-31 |
4 |
AS |
$15.97 |
$22,182 |
D/D |
(1,389) |
11,557 |
0 |
- |
|
| DOVA |
Dova Pharmaceuticals, Inc... |
Sr. VP, Product Development |
• – – |
2019-07-01 |
4 |
AS |
$14.17 |
$16,876 |
D/D |
(1,191) |
12,946 |
0 |
- |
|
| DOVA |
Dova Pharmaceuticals, Inc... |
Sr. VP, Product Development |
• – – |
2019-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
7,937 |
14,137 |
0 |
- |
|
| DOVA |
Dova Pharmaceuticals, Inc... |
Sr. VP, Product Development |
• – – |
2017-07-05 |
4 |
B |
$17.00 |
$105,400 |
D/D |
6,200 |
6,200 |
2.74 |
- |
|
7 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
